Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Pain 23Neoplasms 19Cancer Pain 9Colonic Neoplasms 7Breakthrough Pain 7Agnosia 7Breast Neoplasms 5Rectal Neoplasms 4Prostatic Neoplasms 4Lung Neoplasms 4Head and Neck Neoplasms 4Chronic Pain 4Urinary Bladder Neoplasms 3Pancreatic Neoplasms 3Pain, Postoperative 3Sarcoma 2Pleural Effusion, Malignant 2Lymphoma, Follicular 2Diverticulosis, Colonic 2Carcinoma, Hepatocellular 2Burns 2Brain Neoplasms 2Anemia, Sickle Cell 2post laminectomy syndrome 1Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Vipoma 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1

Interventions

Surveys and Questionnaires 5Oxygen 2Dexamethasone 2Calcium Dobesilate 2Acupuncture Therapy 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tiotropium Bromide 1Sugars 1Standard of Care 1Respiratory Therapy 1Rehabilitation 1Psychiatric Rehabilitation 1Midazolam 1Losartan 1Lisinopril 1Hypnosis 1Furosemide 1Fentanyl 1Exercise 1Educational Status 1Early Intervention, Educational 1Dexmedetomidine 1Caregivers 1Buspirone 1Behavior Therapy 1Aromatherapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Dyspnea × Fentanyl × Clear all
NCT01515566 2014-08-22

Breakthrough Dyspnea Fentanyl Study in Cancer Patients

M.D. Anderson Cancer Center

Phase 1/2 Completed
26 enrolled 7 charts
Other

Dyspnea

Data powered by HemOnc (CC BY 4.0) Colophon âš¡